Dr. Amal Saadallah [MD, PhD, FCAP, FAIHQ, DHA, CPHQ]

Dr. Amal Saadallah is a clinical pathology consultant physician in a specialized clinical laboratory located in a major tertiary care hospital in Saudi Arabia where newborn screening is one of its analytical areas. In this laboratory; she has been a section head and a clinical pathology consultant for ten years. She also directs a quality improvement and safety taskforce at the Laboratory. She is an adjunct clinical pathology assistant professor at a local medical college. She is international fellow of the College of American Pathologists. She became a Fellow of the American Institute for Healthcare Quality (FAIHQ) in 2009 and a Certified Professional in Healthcare Quality (CPHQ) in 2012. She taught a formal healthcare quality and patient safety curriculum to medical students during academic years 2010 and 2011. She gained a doctorate degree in health administration (DHA) in late 2010 from University of Phoenix. She is a faculty advisor to a local Institute for Healthcare Improvement (IHI) Chapter. In April 2012, she has formulated a Quality & Safety Group as a sub-section of Undergraduate Research Committee, Medical Student Association at the local medical college. She had a doctorate Degree in Clinical Pathology (PhD) in 1995 between an Egyptian University School of Medicine and the University of Pennsylvania, Department of Pathology & Laboratory Medicine. She has been a clinical pathology college faculty in another Middle Eastern country from 1990 to 2012.

Swapna Abhyankar, MD

Dr. Abhyankar is a Staff Scientist at the National Library of Medicine (NLM), which is part of the National Institutes of Health. She is also a practicing pediatrician with several years of clinical experience. She attended Stanford University in California as an undergraduate, the University of Michigan Medical School, and did her pediatrics internship and residency at Children’s National Medical Center in Washington, D.C. She completed a post-doctoral Clinical Informatics fellowship at NLM in 2011. One of her primary projects at NLM has been developing standard terminology and messaging guidance for newborn screening and long-term follow-up for patients diagnosed with conditions found during newborn screening.

Jim Bialick

Jim Bialick is an expert on health information technology as it pertains to newborn health and public health systems. He has a keen interest in the overall modernization of healthcare and seeks to work with stakeholders to develop new and innovative methods to personalize the care experience in a way that will improve health outcomes and reduce their costs.

He is a co-founder and the Executive Director of the Newborn Coalition as well as the Newborn Foundation, two action-oriented and health IT forward organizations that work to develop and increase the awareness of technology solutions that improve care delivery and preventative screening infrastructure for our most vulnerable citizens.

The Newborn Foundation and the Newborn Coalition work both domestically and internationally to leverage health IT and technology innovation to improve outcomes and reduce disparities for the newest, most vulnerable citizens.

Jim’s work has extended beyond traditional health technologies into developing systems that facilitate collaboration between novel stakeholders in new and innovative ways. He strongly believes that technology and infrastructure should play a larger role in the early identification and prevention of newborn health issues. These medical innovations and the systems that support them are critical in ensuring that newborns and their families have access to the right care in a timely fashion that will allow them to receive life-saving interventions and effective follow-up throughout their lives.

He is a former staffer of the HIT Standards Committee, vocal participant in the public proceedings of the Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children, and a former community organizer working closely with the Mexican Secretary of Health.

Dr. Karla Bartholomew

Dr. Karla Bartholomew is an Assistant Professor of Public Health Policy in the University of Wisconsin – Milwaukee’s School of Public Health. Her work and research focus on the intersection of public health law and public health by evaluating the impact of law and policy on public health and exploring the development of policies and laws that positively affect public health. Her research includes policies addressing maternal, infant, and child health, chronic disease prevention, environmental health, and global health. She is a member of the Carrier Screening/Newborn Screening Workgroup of the American Public Health Association’s Genomics Forum. Her background includes health law, public health practice and administration, community health education, and clinical experience as a Physician Assistant.

Dr. Hilde Laedermans

Dr. Hilde Laedermans is head of the laboratory of neonatal screening, Pediatric Lab (Pr Goyens), free university of Brussels (ULB). She accomplished her PhD in the department of Pharmacology & Cardiovascular Research Institute Maastricht, Maastricht University, The Netherlands (title project: Markers for myofibroblasts to identify heart failure-prone patient after myocardial infarction). Post-Doc scientist  in the department of Allergy and Immunology CCHMC (Children’s Hospital), Cincinnati, Ohio and in the department of Molecular and Cellular Medicine, University of Leuven, Belgium. 1 patent (Antagonistic peptides for frizzled-1 and frizzled-2), member of the Dutch society of Pharmacology (NVF), member of the American Heart Association (AHA), boardmember Metabolics.be, member advisoratory board Flemisch community for neonatal screening, member advisoratory board Franch community for neonatal screening.

Mustapha Chamekh, PhD, HDR

Mustapha Chamekh, PhD, HDR, is an associate professor of microbiology/immunology at the Faculty of Medicine, Free university of Brussels (ULB) since 2005. After completion of his PhD in biomedical sciences (immunology) at Pasteur Institute of Lille in 1991, on development of innovative molecular methods for immunodiagnosis of parasitic diseases, he coordinated as scientist project leader an international collaborative program based on a patent aiming at evaluating diagnostic potential of new molecular tools in endemic area. Dr Chamekh joined the University of Brussels in 1996 (VUB) as postdoctoral fellow (human capital and mobility, EU) where his work on African trypanosomes contributed to elucidation of the molecular basis of resistance of pathogenic trypanosomes to human innate immunity. In 2002, he joined the faculty of medicine of the ULB as assistant professor and developed a research project on the immunomodulatory role of a co-stimulatory molecule (CD40L). Dr Chamekh joined the institute for medical  immunology (IMI) of the faculty of medicine in 2010 where he is currently developing a research project on the mechanisms of anti-infectious immunity in early life. Awarded cis-Jean Debiesse price (France) in 1992, 2 patents, member of the Belgian immunological society and the Belgian society of microbiology, president of the Belgian-Moroccan society for life science (BIOMATEC).

SOUILMI Fatima-zohra, MD

Assistant Professor of Pediatrics, Faculty of Medicine and Pharmacy of Fes
MD Specialist in Pediatric Nephrology, University Hospital Hassan II of Fes
Member of the French Society of Pediatric Nephrology (SNP)
& the French Speaking Society of Transplantation (SFT).


Aggregate professor, Medical Genetics, Faculty of Medicine and Pharmacy of Fes
MD Specialist in Medical Genetics, University Hospital Hassan II of Fes
General Secretary of the Moroccan Society of Medical Genetics, SMGM
Head of the Medical Genetics and Oncogenetics Unit,
Central Laboratory for Medical Analysis, University Hospital Hassan II of Fes


Assistant Professor of Immunology, Faculty of Medicine and Pharmacy of Fez
Clinical Immunology and Immunogenetics Team
Founding member of the Moroccan Society of Immunology


Assistant Professor, Mohammed First University Oujda/Nador, Morocco
Laboratory of Biotechnology and Genetics
H3 African Bioinformatics Network, Coordinator for Morocco (2012- )
Moroccan society for Telemedicine and eHealth (MSfTeH), Founding President (2011- )

Weather in Fez

Current conditions for Fez as of Thu, 24 Mar 2016 3:58 pm WET

Mostly Cloudy


High: 21° Low: 8°

Mostly Cloudy

Feels like: 15 °C

Barometer: 1015.92 mb and rising

Humidity: 55%

Visibility: 9.99 km

Dewpoint: 8 °C

Wind: 14.48 km/h

Sunrise: 6:16 am

Sunset: 6:34 pm

Powered by Yahoo! Weather